We are live on ! Find out more

2,431 hedge funds and large institutions have $98.2B invested in Amgen in 2023 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 1,047 increasing their positions, 895 reducing their positions, and 144 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more call options, than puts

Call options by funds: $1.48B | Put options by funds: $1.19B

17% more repeat investments, than reductions

Existing positions increased: 1,047 | Existing positions reduced: 895

1% more capital inflows, than outflows

Capital inflows: $4.87B | Capital outflows: $4.83B

0.03% less ownership

Funds ownership: 76.01% → 75.99% (-0.03%)

3% less funds holding

Funds holding: 2,498 → 2,431 (-67)

34% less funds holding in top 10

Funds holding in top 10: 97 → 64 (-33)

38% less first-time investments, than exits

New positions opened: 90 | Existing positions closed: 144

Holders
2,431
Holders Change
-67
Holders Change %
-2.68%
% of All Funds
38.67%
Holding in Top 10
64
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-34.02%
% of All Funds
1.02%
New
90
Increased
1,047
Reduced
895
Closed
144
Calls
$1.48​B
Puts
$1.19​B
Net Calls
+$291​M
Net Calls Change
+$265​M

AMGN Hedge Fund Activity: Q1 2023 in Review

2,431 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2023, worth a combined $98.2B — down 7.8% from $107B a quarter earlier.

Sellers outnumbered buyers: 144 funds closed out of AMGN and 90 opened new positions — a net loss of 54 holders — while 895 trimmed existing stakes and 1,047 added.

The largest buyer was UBS AM, opening a new position worth an estimated $812M. The largest seller was JP Morgan Chase, cutting an estimated $532M.

  • 2,431 institutional investors held Amgen (AMGN) as of Q1 2023, down from 2,498 in Q4 2022.
  • Funds reported $98.2B of Amgen stock for Q1 2023, down 7.8% quarter-over-quarter.
  • 90 funds opened new Amgen positions in Q1 2023 and 144 closed out, a net change of -54 holders.
  • The largest Amgen buyer in Q1 2023 was UBS AM, an estimated $812M added.
  • The largest Amgen seller in Q1 2023 was JP Morgan Chase, an estimated $532M sold.

Based on aggregated 13F filings for Q1 2023.